CHILDREN'S CANCER CAUSE

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$10K

Filings

Firms Hired

Active Period

2000–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	2	1
2025	—	3	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	5	1
2019	—	4	1
2018	—	4	1
2017	—	5	1
2016	—	4	1
2015	$10,000	4	1
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	5	1
2010	—	5	1
2009	—	4	1
2008	—	4	1
2007	—	3	1
2006	$0	1	1
2005	$0	2	1
2004	$0	2	1
2003	$0	3	1
2001	$0	1	1
2000	—	1	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CHILDREN'S CANCER CAUSE	$10,000	91

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	58
SENATE	54
Health & Human Services, Dept of (HHS)	3
Centers For Medicare and Medicaid Services (CMS)	2
Food & Drug Administration (FDA)	2
Natl Institutes of Health (NIH)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	61
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	20
Budget/Appropriations	Budget/Appropriations	18

Bills Explicitly Cited (15)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2607113th Congress

Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act

2014 · third_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Childhood Cancer Research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)

Client expense: — · Firm income: —

Matched citations: H.R.2607

S. 1251113th Congress

Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act

2014 · third_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Childhood Cancer Research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)

Client expense: — · Firm income: —

Matched citations: S.1251

H.R. 2607113th Congress

Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act

2014 · second_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Childhood Cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)

Client expense: — · Firm income: —

Matched citations: H.R.2607

S. 1251113th Congress

Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act

2014 · second_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Childhood Cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)

Client expense: — · Firm income: —

Matched citations: S.1251

Show 11 more cited filings

S. 3817111th Congress

CAPTA Reauthorization Act of 2010

2012 · third_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Childhood cancer survivorship legislation Language modifications for the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, as included in S. 3817

Client expense: — · Firm income: —

Matched citations: S. 3817

H.R. 5651112th Congress

Food and Drug Administration Reform Act of 2012

2012 · second_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Support for language modifications in Best Pharmaceiticals for Children Act and Pediatric Research Equality Act included in H.R.5651 and S.3187.

Client expense: — · Firm income: —

Matched citations: H.R.5651

H.R. 3015112th Congress

Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act of 2011

2012 · first_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Support for funding for childhood cancer registries and surveillance Support for Pediatric, Adolescent and Young Adult Cancer Survivorship Research and Quality of Life Act (H.R. 3015/S. 1613) Support for modifications to Best Pharaceuticals for Children Act and Pediatric Research Equality Act

Client expense: — · Firm income: —

Matched citations: H.R. 3015

H.R. 3015112th Congress

Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act of 2011

2011 · first_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Support for funding for childhood cancer registries and surveillance Support for Pediatric, Adolescent and Young Adult Cancer Survivorship Research and Quality of Life Act (H.R. 3015/S. 1613) Support for and modifications to Best Pharmaceuticals for Children Act and Pediatric Research Equity Act

Client expense: — · Firm income: —

Matched citations: H.R. 3015

H.R. 3015112th Congress

Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act of 2011

2011 · fourth_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Support for Pediatric, Adolescent and Young Adult Cancer Survivorship Research and Quality of Life Act (H.R. 3015/S. 1613) Support for extension of Therapeutic Discovery Project Tax Credit Support for reauthorization of Best Pharmaceuticals for Children Act and Pediatric Research Equity Act

Client expense: — · Firm income: —

Matched citations: H.R. 3015

H.R. 3015112th Congress

Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act of 2011

2011 · third_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Support for Pediatric, Adolescent and Young Adult Cancer Survivorship Research and Quality of Life Act (H.R. 3015/S. 1613) Support for the Children's Hospital Graduate Medical Education (CHGME) program Support for the National Center for Advancing Trnslational Sciences (NCATS)

Client expense: — · Firm income: —

Matched citations: H.R. 3015

H.R. 2109111th Congress

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

2010 · third_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Reauthorization of the Best Pharmaceuticals for Children Act, H.R. 2109 Childhood Cancer Survivorship legislation, health care reform benefits

Client expense: — · Firm income: —

Matched citations: H.R. 2109

H.R. 2109111th Congress

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

2010 · second_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2109 -- Childhood Cancer Survivorship Research and Quality of Life Act, all titles Appropriations -- Labor/HHS bill for Cures Acceleration Network

Client expense: — · Firm income: —

Matched citations: H.R. 2109

H.R. 2109111th Congress

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

2010 · first_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

HR2109, cancer survivorship health care reform

Client expense: — · Firm income: —

Matched citations: HR2109

H.R. 2109111th Congress

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

2009 · fourth_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2109 Cancer Survivorship, Health Care Reform

Client expense: — · Firm income: —

Matched citations: H.R. 2109

H.R. 2109111th Congress

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

2009 · third_quarter · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text and reported amounts

Childhood Cancer Survivorship Bill (HR 2109)

Client expense: — · Firm income: —

Matched citations: HR 2109

Source: Senate LDA

CHILDREN'S CANCER CAUSE — Lobbying Disclosure | Poliscope